Wright Medical Group NV
(NASDAQ : WMGI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
1.25%151.550.7%$1845.44m
MDTMedtronic Plc
0.69%112.490.6%$503.42m
TMOThermo Fisher Scientific, Inc.
0.69%320.281.0%$369.91m
ABTAbbott Laboratories
1.03%85.780.8%$365.41m
ISRGIntuitive Surgical, Inc.
1.00%580.562.4%$319.93m
BDXBecton, Dickinson & Co.
1.10%263.921.1%$302.32m
EWEdwards Lifesciences Corp.
-0.15%229.991.2%$286.92m
SYKStryker Corp.
0.70%199.371.3%$260.56m
BSXBoston Scientific Corp.
1.67%44.551.1%$254.55m
BAXBaxter International, Inc.
0.46%83.391.8%$207.07m
DXCMDexCom, Inc.
-2.59%206.878.3%$199.34m
PODDInsulet Corp.
0.36%180.836.7%$161.15m
MTDMettler-Toledo International, Inc.
1.27%772.035.4%$160.36m
HOLXHologic, Inc.
1.69%53.491.7%$147.81m
ABMDABIOMED, Inc.
0.64%180.023.3%$146.10m

Company Profile

Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.